PCRX FY 2022 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$971M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$667M+23.1% YoY

Gross Profit

$468M70.1% margin

Operating Income

$60M9.0% margin

Net Income

$16M2.4% margin

EPS (Diluted)

$0.34

Cash Flow

Operating Cash Flow

$145M

Free Cash Flow

$115M

Stock-Based Comp.

$48M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$906M

Stockholders' Equity

$775M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$667M	$542M	+23.1%
Gross Profit	$468M	$401M	+16.5%
Operating Income	$60M	$90M	-33.3%
Net Income	$16M	$42M	-62.1%